HELO vs. HALO
HELO (JPMorgan Hedged Equity Laddered Overlay ETF) is Options Trading fund actively managed by JPMorgan, while HALO (Halozyme Therapeutics, Inc.) is a stock. Over the past year, HELO returned 11.65% vs 19.12% for HALO. At a 0.28 correlation, their price movements are largely independent.
Performance
HELO vs. HALO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, HELO achieves a 2.52% return, which is significantly higher than HALO's -1.52% return.
HELO
- 1D
- -0.07%
- 1M
- 0.73%
- YTD
- 2.52%
- 6M
- 3.21%
- 1Y
- 11.65%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
HALO
- 1D
- -2.73%
- 1M
- 3.63%
- YTD
- -1.52%
- 6M
- -0.39%
- 1Y
- 19.12%
- 3Y*
- 25.45%
- 5Y*
- 11.28%
- 10Y*
- 21.28%
HELO vs. HALO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
HELO JPMorgan Hedged Equity Laddered Overlay ETF | 2.52% | 7.82% | 18.05% | 6.30% |
HALO Halozyme Therapeutics, Inc. | -1.52% | 40.77% | 29.36% | -3.25% |
Correlation
The correlation between HELO and HALO is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.23 |
Correlation (All Time) Calculated using the full available price history since Oct 2, 2023 | 0.28 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HELO vs. HALO — Risk / Return Rank
HELO
HALO
HELO vs. HALO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for JPMorgan Hedged Equity Laddered Overlay ETF (HELO) and Halozyme Therapeutics, Inc. (HALO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| HELO | HALO | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.89 | 0.64 | +1.24 |
Sortino ratioReturn per unit of downside risk | 2.65 | 1.06 | +1.59 |
Omega ratioGain probability vs. loss probability | 1.38 | 1.13 | +0.25 |
Calmar ratioReturn relative to maximum drawdown | 2.05 | 0.75 | +1.30 |
Martin ratioReturn relative to average drawdown | 9.10 | 1.45 | +7.65 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| HELO | HALO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.89 | 0.64 | +1.24 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.29 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.50 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 1.65 | 0.23 | +1.42 |
Drawdowns
HELO vs. HALO - Drawdown Comparison
The maximum HELO drawdown since its inception was -10.89%, smaller than the maximum HALO drawdown of -74.26%. Use the drawdown chart below to compare losses from any high point for HELO and HALO.
Loading charts...
Drawdown Indicators
| HELO | HALO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -10.89% | -74.26% | +63.37% |
Max Drawdown (1Y)Largest decline over 1 year | -5.76% | -24.13% | +18.37% |
Max Drawdown (3Y)Largest decline over 3 years | — | -33.92% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -49.06% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -49.06% | — |
Current DrawdownCurrent decline from peak | -0.07% | -18.40% | +18.33% |
Average DrawdownAverage peak-to-trough decline | -1.18% | -31.91% | +30.73% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 1.30% | 12.56% | -11.26% |
Volatility
HELO vs. HALO - Volatility Comparison
The current volatility for JPMorgan Hedged Equity Laddered Overlay ETF (HELO) is 0.66%, while Halozyme Therapeutics, Inc. (HALO) has a volatility of 10.41%. This indicates that HELO experiences smaller price fluctuations and is considered to be less risky than HALO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HELO | HALO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 0.66% | 10.41% | -9.75% |
Volatility (6M)Calculated over the trailing 6-month period | 5.00% | 24.18% | -19.18% |
Volatility (1Y)Calculated over the trailing 1-year period | 6.20% | 29.89% | -23.69% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 7.96% | 39.47% | -31.51% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 7.96% | 42.89% | -34.93% |
Dividends
HELO vs. HALO - Dividend Comparison
HELO's dividend yield for the trailing twelve months is around 0.62%, while HALO has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
HALO Halozyme Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% |
HELO JPMorgan Hedged Equity Laddered Overlay ETF | 0.62% | 0.67% | 0.60% | 0.19% |
Frequently Asked Questions
HELO and HALO have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
HALO has higher volatility (10.41%) compared to HELO (0.66%). In terms of maximum drawdown, HELO dropped -10.89% vs HALO's -74.26%.
HELO currently has the higher Sharpe Ratio (1.89 vs 0.64), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for HELO and HALO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer